Pilot study to test the efficacy and safety of activated recombinant factor VII (NovoSeven) in the treatment of refractory hemorrhagic cystitis following high-dose chemotherapy [3]

A. A. Ashrani, D. A. Gabriel, J. L. Gajewski, D. R. Jacobs, D. J. Weisdorf, N. S. Key

Research output: Contribution to journal › Letter › peer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'Pilot study to test the efficacy and safety of activated recombinant factor VII (NovoSeven) in the treatment of refractory hemorrhagic cystitis following high-dose chemotherapy [3]'. Together they form a unique fingerprint.